0001415889-16-005891.txt : 20160513
0001415889-16-005891.hdr.sgml : 20160513
20160513172506
ACCESSION NUMBER: 0001415889-16-005891
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160419
FILED AS OF DATE: 20160513
DATE AS OF CHANGE: 20160513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medovex Corp.
CENTRAL INDEX KEY: 0001591165
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3729 HARDEE AVENUE
CITY: ATLANTA
STATE: GA
ZIP: 30341
BUSINESS PHONE: (404) 393-6989
MAIL ADDRESS:
STREET 1: 3729 HARDEE AVENUE
CITY: ATLANTA
STATE: GA
ZIP: 30341
FORMER COMPANY:
FORMER CONFORMED NAME: SpineZ
DATE OF NAME CHANGE: 20131105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gorlin Jarrett S
CENTRAL INDEX KEY: 0001629409
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36763
FILM NUMBER: 161649647
MAIL ADDRESS:
STREET 1: 3279 HERDEE AVE
CITY: ATLANTA
STATE: GA
ZIP: 30341
4/A
1
form4a-05132016_020555.xml
X0306
4/A
2016-04-19
2016-04-21
0001591165
Medovex Corp.
MDVX
0001629409
Gorlin Jarrett S
3279 HARDEE AVENUE
ATLANTA
GA
30341
true
true
false
false
CHIEF EXECUTIVE OFFICER
Common Stock
2016-04-19
4
P
0
43028
1.255
A
560065
D
Warrant to purchase shares of Common Stock
1.30
2016-04-19
4
P
0
21514
0
A
2016-10-19
2021-04-19
Common Stock
21514
62314
D
On April 21, 2016, the Reporting Person filed a Form 4 with the Commission. The previously filed Form 4 reported the purchase of shares of common stock (the "Shares") of MedoveX Corporation (the "Company"). In compliance with NASDAQ rules and regulations, the Reporting Person is hereby amending his report to accurately reflect the correct number of Shares purchased which was reduced, effectively increasing the purchase price from $1.225 to $1.255.
Represents shares held by The Jarrett S. & Rebecca L. Gorlin Family Limited Partnership. Mr. Gorlin disclaims beneficial ownership of these shares.
The Warrant is initially exercisable six months following the date of issuance (04/19/2016) for a period of five (5) years from the date of issuance
On April 21, 2016, the Reporting Person filed a Form 4 with the Commission. The previously filed Form 4 reported the purchase of a warrant to purchase shares of common stock (the "Warrant") of MedoveX Corporation (the "Company"). In compliance with NASDAQ rules and regulations, the Reporting Person is hereby amending his report to accurately reflect the correct number of underlying shares that the Warrant represents, which was reduced pursuant to NASDAQ guidelines.
/s/ Jarrett Gorlin
2016-05-13